Form 4: STAAR Surgical CEO Stephen Farrell Receives Sign-On Equity Award

Sentiment:

SEC Form 4 Filing


Stephen Farrell, the newly appointed President and CEO of STAAR Surgical, was granted 200,000 restricted stock units (RSUs) as a sign-on equity award.

Summary

  • Stephen C. Farrell, the President and CEO of STAAR Surgical, received a sign-on equity award of 200,000 restricted stock units (RSUs) on February 26, 2025.
  • Each RSU represents the right to receive one share of STAAR Surgical's common stock upon vesting.
  • The RSUs will vest in three equal installments: 1/3 on February 26, 2026, 1/3 on February 26, 2027, and 1/3 on February 26, 2028.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of RSUs is a standard practice and indicates confidence in the new CEO. The vesting schedule promotes long-term value creation.

Positives

  • The grant of RSUs aligns the CEO's interests with those of the shareholders, incentivizing him to drive long-term value creation.
  • The vesting schedule encourages long-term commitment from the CEO.

Industry Context

Equity awards are a common practice in the industry to attract and retain top executive talent. The size and vesting schedule of the award are typical for a CEO sign-on bonus.

Comparison to Industry Standards

  • Sign-on equity grants for CEOs in the medical device industry typically range from 1x to 3x their base salary, vesting over 3-4 years.
  • Comparable companies like Alcon or Johnson & Johnson also use RSUs as part of their executive compensation packages.
  • The vesting schedule of 1/3 per year over three years is a standard practice to ensure long-term alignment.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
President & CEOUnknownStephen C. Farrell02/26/2025Appointment as President and Chief Executive Officer

Stakeholder Impact

  • Shareholders: The equity award aligns the CEO's interests with those of the shareholders, potentially leading to increased shareholder value.
  • Employees: The appointment of a new CEO and the associated equity award can impact employee morale and expectations.
  • Customers: The change in leadership could influence the company's strategic direction and product development, potentially affecting customers.

Key Dates

DateDescription
02/26/2025Date of the RSU grant to Stephen C. Farrell.
02/26/2026First vesting date for 1/3 of the RSUs.
02/26/2027Second vesting date for 1/3 of the RSUs.
02/26/2028Final vesting date for 1/3 of the RSUs.
02/28/2025Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.